Company Filing History:
Years Active: 1999
Title: Innovations by Csilla Fenczik
Introduction
Csilla Fenczik is a notable inventor based in Encinitas, California. She has made significant contributions to the field of integrin research, particularly in identifying regulators of integrin activation. Her work has implications for drug design and cellular signaling.
Latest Patents
Fenczik holds a patent for "Methods and cell lines for identification of regulators of integrin." This patent describes a method for identifying regulators of integrin activation by establishing a selected cell line that contains a functional integrin and a chimeric polypeptide. The chimeric polypeptide has a cytoplasmic domain of an integrin subunit fused to a polypeptide containing extracellular and transmembrane domains that are not functional integrin domains. This innovation allows for the inhibition of signaling activities of the functional integrin by interacting with integrin regulator molecules in the cytoplasm. The patent also outlines methods for designing drugs to modify integrin function and cell lines for screening regulators of integrin activation.
Career Highlights
Fenczik is affiliated with The Scripps Research Institute, where she conducts her research. Her work has been instrumental in advancing the understanding of integrin functions and their regulatory mechanisms.
Collaborations
One of her notable collaborators is Mark H. Ginsberg, who has worked alongside her in various research endeavors.
Conclusion
Csilla Fenczik's innovative work in integrin research and her patent contributions highlight her role as a significant inventor in the field. Her research continues to pave the way for advancements in drug design and cellular biology.